PRODUCTS
« BACK TO "INTERNATIONAL"
Strontium Ranelate is indicated for the treatment of osteoporosis in postmenopausal women to reduce the risk of vertebral and hip fractures.
Strontium Ranelate affects bone structure and mineralization.It increases bone formation in bone tissue culture as well as osteoblast precursor replication and collagen synthesis in bone cell culture and reduces bone resorption by decreasing osteoclast differentiation and resorbing activity.
Under Development
Strontium Ranelate affects bone structure and mineralization.It increases bone formation in bone tissue culture as well as osteoblast precursor replication and collagen synthesis in bone cell culture and reduces bone resorption by decreasing osteoclast differentiation and resorbing activity.
Under Development